Eversept Partners, LP Portfolio Holdings

Eversept Partners, LP

  • $993 Million
  • Q2 2025

Eversept Partners, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $993 Million distributed in 68 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $135M, Perkinelmer Inc with a value of $61.7M, Vera Therapeutics, Inc. with a value of $56.1M, Vaxcyte, Inc. with a value of $42.2M, and Hca Healthcare, Inc. with a value of $38.3M.

Examining the 13F form we can see an increase of $88.8M in the current position value, from $904M to 993M.

Eversept Partners, LP is based out at New York, NY

Below you can find more details about Eversept Partners, LP portfolio as well as his latest detailed transactions.

Portfolio value $993 Million
Healthcare: $877 Million
ETFs: $95 Million
Basic Materials: $20.5 Million
Financial Services: $558,000

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.64B
$42.2 Million 4.25% of portfolio
1,298,514
Q2 2025 Added 133.1%
$5.72B
$34.6 Million 3.48% of portfolio
839,284
Q2 2025 Added 68.12%
$2.33B
$21.3 Million 2.15% of portfolio
164,473
Q2 2025 Reduced 11.78%
$2.52B
$20.3 Million 2.04% of portfolio
394,139
Q2 2025 Added 40.71%
$7.86B
$16.3 Million 1.64% of portfolio
155,868
Q2 2025 Reduced 55.72%
$3.74B
$15.3 Million 1.54% of portfolio
277,316
Q2 2025 Reduced 49.31%
$2.68B
$11.8 Million 1.19% of portfolio
232,175
Q2 2025 New
$4.74B
$10 Million 1.01% of portfolio
169,643
Q2 2025 Reduced 12.05%
$4.33B
$6.89 Million 0.69% of portfolio
130,924
Q2 2025 Added 86.16%
$9.47B
$6.14 Million 0.62% of portfolio
20,600
Q2 2025 Reduced 13.21%
$3.78B
$3.25 Million 0.33% of portfolio
31,496
Q2 2025 Reduced 80.19%
$8.94B
$2.32 Million 0.23% of portfolio
18,620
Q2 2025 Added 0.91%

Summary

  • Portfolio
  • No. of Stocks 68
  • Current Value $993 Million
  • Prior Value $904 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 19 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 21 stocks
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email